Successfully established long-term industry-patient organisation partnerships in multiple rare diseases, accelerating the path to innovation for patients, resulting in more effective care delivery environments.
Initiated major policy and advocacy change over the recent years with measurable international impact. Brought two major international health policy developments to success with huge impact on health for many people.
Brought three pharmaceutical products to market leadership, contributed towards successfully launching three highly innovative health products.